Risk factors in the development of esophageal adenocarcinoma

American Journal of Gastroenterology

Volumn 108, Issue 2, 2013, Pages 200-207

  Pohl, Heiko ^a,b   Wrobel, Katharina ^c   Bojarski, Christian ^c   Voderholzer, Winfried ^c   Sonnenberg, Amnon ^d   Rösch, Thomas ^e   Baumgart, Daniel C ^c  

^a VA MEDICAL CENTER   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d PORTLAND VA MEDICAL CENTER   (United States)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BARRETT ESOPHAGUS; BODY MASS; CANCER RISK; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE PREDISPOSITION; ENDOSCOPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS DYSPLASIA; FEMALE; FOOD INTAKE; FRUIT; GASTROESOPHAGEAL REFLUX; HIATUS HERNIA; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; VEGETABLE;

ADENOCARCINOMA; ADULT; AGED; BARRETT ESOPHAGUS; BODY MASS INDEX; CASE-CONTROL STUDIES; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; FOOD HABITS; FRUIT; GASTROESOPHAGEAL REFLUX; GERMANY; HERNIA, HIATAL; HUMANS; MALE; METAPLASIA; MIDDLE AGED; ODDS RATIO; QUESTIONNAIRES; RISK FACTORS; SEX FACTORS; SMOKING; TIME FACTORS; VEGETABLES;

EID: 84873567161     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.387     Document Type: Article

References (40)

1. Pohl H, Welch HG. The role of overdiagnosis and reclassifi cation in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005; 97: 142-6. (Pubitemid 40277094)
2. de Jonge PJ, van Blankenstein M, Looman CW et al. Risk of s oesophagus: A Dutch?malignant progression in patients with Barrett ′ nationwide cohort study. Gut 2011; 59: 1030-6.
3. El-Serag HB. The epidemic of esophageal adenocarcinoma. Gastroenterol Clin North Am 2002; 31: 421-40, viii. (Pubitemid 34761220)
4. Cook MB, Kamangar F, Whiteman DC et al. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: A pooled analysis from the international BEACON consortium. J Natl Cancer Inst 2010; 102: 1344-53.
5. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: Obesity and the risk for gastroesophageal refl ux disease and its complications. Ann Intern Med 2005; 143: 199-211. (Pubitemid 41076753)
6. Cheng KK, Sharp L, McKinney PA et al. A case-control study of oesophageal adenocarcinoma in women: A preventable disease. Br J Cancer 2000; 83: 127-32. (Pubitemid 30352729)
7. Avidan B, Sonnenberg A, Schnell TG et al. Hiatal hernia s length, and severity of acid refl ux are all risk factors for?size, Barrett ′ esophageal adenocarcinoma. Am J Gastroenterol 2002; 97: 1930-6.
8. Th eisen J, Peters JH, Stein HJ. Experimental evidence s esophagus. World?for mutagenic potential of duodenogastric juice on Barrett ′ J Surg 2003; 27: 1018-20. (Pubitemid 37186235)
9. Lagergren J, Bergstrom R, Lindgren A et al. Symptomatic gastroesophageal refl ux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-31. (Pubitemid 29142625)
10. Lassen A, Hallas J, de Muckadell OB. Esophagitis: Incidence and risk of esophageal adenocarcinoma-a population-based cohort study. Am J Gastroenterol 2006; 101: 1193-9. (Pubitemid 43829981)
11. Chow WH, Finkle WD, McLaughlin JK et al. The relation of gastroesophageal refl ux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA 1995; 274: 474-7.
12. Shaheen NJ, Crosby MA, Bozymski EM et al. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000; 119: 333-8. (Pubitemid 30621983)
13. Bhat S, Coleman HG, Yousef F et al. Risk of malignant s esophagus patients: Results from a large?progression in Barrett ′ population-based study. J Natl Cancer Inst 2011; 103: 1049-57.
14. Hvid-Jensen F, Pedersen L, Drewes AM et al. Incidence of s esophagus. N Engl J Med 2011;?adenocarcinoma among patients with Barrett ′ 365 : 1375-83.
15. Rastogi A, Puli S, El-Serag HB et al. Incidence of s esophagus and high-grade?esophageal adenocarcinoma in patients with Barrett ′ dysplasia: A meta-analysis. Gastrointest Endosc 2008; 67: 394-8. (Pubitemid 351260043)
16. Konda VJ, Ross AS, Ferguson MK et al. Is the risk of s?concomitant invasive esophageal cancer in high-grade dysplasia in Barrett ′ esophagus overestimated? Clin Gastroenterol Hepatol 2008; 6: 159-64.
17. Nguyen DM, El-Serag HB, Henderson L et al. Medication s esophagus. Clin?usage and the risk of neoplasia in patients with Barrett ′ Gastroenterol Hepatol 2009; 7: 1299-304.
18. Eloubeidi MA, Provenzale D. Clinical and demographic s esophagus among patients with gastroesophageal refl?predictors of Barrett ′ ux disease: A multivariable analysis in veterans. J Clin Gastroenterol 2001; 33: 306-9. (Pubitemid 32880970)
19. Oberg S, Wenner J, Johansson J et al. Barrett esophagus: Risk factors for progression to dysplasia and adenocarcinoma. Ann Surg 2005; 242: 49-54. (Pubitemid 40917967)
20. Steevens J, Schouten LJ, Driessen AL et al. A prospective cohort study on overweight, smoking, alcohol consumption, and risk s esophagus. Cancer Epidemiol Biomarkers Prev 2010.?of Barrett
21. Smith KJ, O ' Brien SM, Green AC et al. Current and past s esophagus. Clin?smoking signifi -cantly increase risk for Barrett ′ Gastroenterol Hepatol 2009; 7: 840-8.
22. Menke-Pluymers MB, Hop WC, Dees J et al. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer 1993; 72: 1155-8. (Pubitemid 23224979)
23. Gray MR, Donnelly RJ, Kingsnorth AN. The role of s columnar lined?smoking and alcohol in metaplasia and cancer risk in Barrett ′ oesophagus. Gut 1993; 34: 727-31. (Pubitemid 23185093)
24. de Jonge PJ, Steyerberg EW, Kuipers EJ et al. Risk s?factors for the development of esophageal adenocarcinoma in Barrett ′ esophagus. Am J Gastroenterol 2006; 101: 1421-9. (Pubitemid 43980612)
25. Coleman HG, Bhat S, Johnston BT et al. Tobacco smoking increases the risk of high-grade dysplasia and cancer among patients with s esophagus. Gastroenterology 2012; 142: 233?Barrett ′-40.
26. Cook MB, Greenwood DC, Hardie LJ et al. A systematic s?review and meta-analysis of the risk of increasing adiposity on Barrett ′ esophagus. Am J Gastroenterol 2008; 103: 292-300. (Pubitemid 351248722)
27. Vaughan TL, Kristal AR, Blount PL et al. Nonsteroidal anti-infl ammatory drug use, body mass index, and anthropometry in relation to s esophagus. Cancer?genetic and fl ow cytometric abnormalities in Barrett ′ Epidemiol Biomarkers Prev 2002; 11: 745-52. (Pubitemid 34851909)
28. Moe GL, Kristal AR, Levine DS et al. Waist-to-hip ratio, weight gain, and dietary and serum selenium are associated with DNA content fl s esophagus. Nutr Cancer 2000; 36: 7?ow cytometry in Barrett ′-13.
29. Chao DL, Sanchez CA, GalipeaüPC et al. Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with s esophagus: A long-term prospective study. Clin Cancer Res 2008; 14:?Barrett ′ 6988-95.
30. Mehta S, Johnson IT, Rhodes M. Systematic review: The chemoprevention of oesophageal adenocarcinoma. Aliment Pharmacol Th er 2005; 22: 759-68. (Pubitemid 41564354)
31. Wolfgarten E, Rosendahl U, Nowroth T et al. Coincidence of nutritional habits and esophageal cancer in Germany. Onkologie 2001; 24: 546-51. (Pubitemid 34088231)
32. Gonzalez CA, Pera G, Agudo A et al. Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer 2006; 118: 2559-66.
33. Murphy SJ, Anderson LA, Ferguson HR et al. Dietary antioxidant and mineral intake in humans is associated with reduced risk of esophageal adenocarcinoma but not refl ux esophagitis or Barrett's esophagus. J Nutr 2010; 140: 1757-63.
34. El-Serag HB, Satia JA, Rabeneck L. Dietary intake and the risk of gastrooesophageal refl ux disease: A cross sectional study in volunteers. Gut 2005; 54: 11-7. (Pubitemid 40007212)
35. Kubo A, Levin TR, Block G et al. Dietary antioxidants, s esophagus. Am J?fruits, and vegetables and the risk of Barrett ′ Gastroenterol 2008; 103 : 1614-23; quiz 1624.
36. Sonnenberg A, Lash RH, Genta RM. A national study of Helicobactor pylori infection in gastric biopsy specimens. Gastroenterology 2010; 139: 1894-901 e2; quiz e12.
37. Sharma P, Vakil N. Review article: Helicobacter pylori and refl ux disease. Aliment Pharmacol Th er 2003; 17: 297-305. (Pubitemid 36259392)
38. El-Serag H, Hill C, Jones R. Systematic review: The epidemiology of gastrooesophageal refl ux disease in primary care, using the UK General Practice Research Database. Aliment Pharmacol Th er 2009; 29: 470-80.
39. Schnell TG, Sontag SJ, Chejfec G et al. Long-term s esophagus with high-grade dysplasia.?nonsurgical management of Barrett ′ Gastroenterology 2001; 120: 1607-19. (Pubitemid 32523480)
40. Sontag SJ, Sonnenberg A, Schnell TG et al. The long-term natural history of gastroesophageal refl ux disease. J Clin Gastroenterol 2006; 40: 398-404. (Pubitemid 44318158)